HBV pgRNA induces chronic inflammation in an IL-1β-dependent manner

Introduction: Chronic hepatitis B (CHB) is a widespread form of hepatitis B infection with advanced complications if unsupervised and untreated. It was previously reported that pregenomic RNA (pgRNA) can be detected in blood circulation as an indirect marker of HBV transcriptional activity. The aim of this study was to investigate the transcriptomic profile of pgRNA-positive patients with CHB in comparison to pgRNA-negative patients and to evaluate its role in innate immunity. Materials and methods: A total of 88 patients with CHB who were receiving nucleoside analogs (NAs) were enrolled in this study. The viral load and genotype, HBV pgRNA, and biochemical and virological markers were determined. Samples from eight CHB HBeAg-negative patients were sequenced. Four of them were positive for HBV pgRNA, while the rest were negative. These data were processed via bioinformatic tools. Bioinformatic analyses revealed common pathways such as platelet activation and neutrophil degranulation, for which experimental setups were organized. Platelet activation, as well as platelet-neutrophil interactions, was examined. Furthermore, the synthesis and expression of interleukins IL-1β, IL-17A, and LL-37 were studied. Results: synthesis of the peptide LL-37 were observed in platelets stimulated with HBV pgRNA-positive serum. Furthermore, a combined study of platelet-neutrophil interactions revealed the development of a proinflammatory phenotype characterized by high levels of IL-1β in neutrophils, accompanied by minimal NET formation. In conclusion, those findings were intended to demonstrate the overexpression of IL-1β and LL-37 in the liver tissue of patients with CHB. Conclusions: This study demonstrated that HBV pgRNA activates platelets in an autophagy-dependent manner. Moreover, the platelet-neutrophil axis is responsible for a proinflammatory phenotype in which IL-1β is overexpressed.